Richard S. Good
Clydebank, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Non-invasive endotyping improves treatment satisfaction and prescribing appropriateness in patients with angina and no obstructive coronary artery disease.
Journal: Open heart
Published: March 30, 2026
Stratified medicine with eplerenone for myocardial infarction or injury and no obstructive coronary arteries: A registry-based basket trial.
Journal: American heart journal
Published: March 13, 2026
Pre-perfusion coronary wedge pressure and microvascular obstruction in anterior ST elevation myocardial infarction (STEMI): An analysis from the EUROICE study.
Journal: International journal of cardiology
Published: February 23, 2026
Endotype-informed therapy and effects on illness perception and psychological health in patients with chest pain and no obstructive coronary artery disease.
Journal: European heart journal. Quality of care & clinical outcomes
Published: January 28, 2026
Infarct-Related Myocardial Resistance Before Reperfusion in Patients With Acute Myocardial Infarction to Predict Microvascular Injury and Clinical Outcomes.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: July 16, 2025
Novel Contrast-Derived Indices of Coronary Microvascular Function: Potential Clinical and Cost Benefits.
Journal: Circulation. Cardiovascular interventions
Published: May 01, 2025
Rapid response letter.
Journal: European heart journal. Acute cardiovascular care
Published: April 15, 2025
Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial.
Journal: European heart journal
Published: March 17, 2025
Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?
Journal: Frontiers in medical technology
Published: December 16, 2024
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).
Journal: European journal of heart failure
Published: September 27, 2024
Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial.
Journal: Heart (British Cardiac Society)
Published: July 01, 2024
Last Updated: 09/26/2026